Search results
Results from the WOW.Com Content Network
An Act to amend sections 3719.21, 4729.99, 4776.02, and 4776.04 and to enact section 4729.42 of the Revised Code to prohibit unauthorized pharmacy-related drug conduct relative to persons employed as pharmacy technicians. Introduced: December 5, 2007: House voted: December 16, 2008 (96-1) Senate voted: December 17, 2008 (31-0) Signed into law
A patient suffering from cancer with poor respiratory health died three days after Elizabeth Lee, a pharmacist, dispensed or co-dispensed the wrong drug. A full investigation of facts followed and Lee reported the error, which was, before trial, found not to have been the primary cause of death.
The Food and Drug Administration receives more than 100,000 annual reports of medication errors — preventable events, such as prescribing the wrong dosage, that could harm patients or lead to ...
Conscience clauses are legal clauses attached to laws in some parts of the United States and other countries which permit pharmacists, physicians, and/or other providers of health care not to provide certain medical services for reasons of religion or conscience. It can also involve parents withholding consenting for particular treatments for ...
State regulators faulted two hospitals in Southern California for medication errors that put patients at risk, including one who suffered a brain bleed after receiving repeated doses of blood thinner.
The regulations set out specific requirements for "nonidentification." Research — This exception allows disclosure to researchers conducting certain types of research projects. If protected health information is involved, the HIPAA privacy and security rules also apply. Food and Drug Administration (FDA) — PSWP may be disclosed to the FDA
The medication is legal — approved by the Food and Drug Administration to prevent stomach ulcers — but it can also be used for abortions, which became illegal in Idaho with few exceptions when ...
The U.S. Kefauver–Harris Amendment or "Drug Efficacy Amendment" is a 1962 amendment to the Federal Food, Drug, and Cosmetic Act. It introduced a requirement for drug manufacturers to provide proof of the effectiveness and safety of their drugs before approval, [1] [2] required drug advertising to disclose accurate information about side effects, and stopped cheap generic drugs being marketed ...